X   

Real-Time Quote

Enter Company or MF
   

Glenmark Pharmaceuticals Ltd. - Research Center

532296  GLENMARK  Group (A) BSE data View Tips   Add to :  Portfolio  |  Watchlist  |  Game

(Rs crore)

Annual results in brief

 Mar ' 09Mar ' 08Mar ' 07Mar ' 06Mar ' 05
Sales 856.11 1,372.69 837.12 618.44 536.43
Operating profit 221.94 481.72 211.26 103.29 113.16
Interest 55.14 41.13 22.95 5.82 16.73
Gross profit 265.48 460.63 194.57 102.79 101.92
EPS (Rs) 8.70 15.64 5.61 2.83 2.68

Annual results in details

 Mar ' 09Mar ' 08Mar ' 07Mar ' 06Mar ' 05
Other income 98.68 20.05 6.26 5.31 5.49
Stock adjustment -15.16 -30.20 -50.80 1.33 -23.76
Raw material 172.90 403.35 304.05 200.45 181.58
Power and fuel-----
Employee expenses 129.83 129.20 94.85 70.53 58.14
Excise-- 34.48 55.50 42.69
Admin and selling expenses--- 187.35-
Research and development expenses-----
Expenses capitalised-----
Other expenses 346.60 388.63 243.28- 164.63
Provisions made-----
Depreciation 19.11 29.44 23.46 17.49 14.98
Taxation 28.15 42.17 36.31 18.00 23.45
Net profit / loss 217.93 389.02 134.80 67.30 63.48
Extra ordinary item -0.30----
Prior year adjustments-----
Equity capital 25.05 24.87 24.01 23.74 23.72
Equity dividend rate-----
Agg.of non-prom. shares (Lacs) 1200.24 1183.67 548.80 535.80 535.75
Agg.of non promotoHolding (%) 47.91 47.59 45.71 45.13 45.16
OPM (%) 25.92 35.09 25.24 16.70 21.10
GPM (%) 27.80 33.07 23.07 16.48 18.81
NPM (%) 22.82 27.93 15.98 10.79 11.71